Cato Institute Releases Framework Distinguishing Decriminalization from Legalization

Cato Framework Defines Two Distinct Reform Pathways

The Cato Institute analysis defines decriminalization as the removal of criminal penalties for possession without creating a legal commercial market, while legalization establishes regulated adult-use sales frameworks. The distinction matters. It carries significant implications for state legislatures drafting reform bills and federal agencies interpreting the Controlled Substances Act.

Under decriminalization models, possession of specified amounts becomes a civil infraction or administrative violation. No legal supply chain exists. Legalization models authorize cultivation, manufacturing, distribution, and retail sales under state regulatory frameworks, typically through licensing regimes administered by cannabis control boards.

The framework arrives as 24 states operate adult-use markets and 14 maintain decriminalization-only statutes. Federal rescheduling to Schedule III wouldn't preempt either model but would eliminate Internal Revenue Code Section 280E tax penalties for state-licensed operators in legalization jurisdictions.

Tax and Banking Implications Diverge Between Models

Decriminalization offers no federal tax relief or banking access because no legal commercial activity exists, while Schedule III reclassification would allow state-licensed businesses in legalization states to deduct ordinary business expenses under 26 U.S.C. § 162. This creates a sharp operational divide.

Decriminalized jurisdictions see continued illicit market dominance. No tax revenue accrues to states. Consumers face inconsistent product quality and no testing requirements. Banking remains unavailable because financial institutions can't service activity that remains federally prohibited under 21 U.S.C. § 841, even if state penalties are removed.

Legalization states with licensed operators would gain Section 280E relief upon Schedule III finalization, estimated to reduce effective tax rates from 70-80% to 25-35%. Banking access would expand under existing FinCEN guidance, which allows depository institutions to service state-compliant cannabis businesses. The Cato analysis notes this asymmetry incentivizes full legalization over decriminalization for states prioritizing regulated markets and tax revenue.

State Legislative Activity Reflects Definitional Confusion

At least six state legislatures in 2026 have introduced bills using "decriminalization" and "legalization" interchangeably, creating statutory ambiguity that the Cato framework aims to resolve. Kentucky HB 72, filed in January 2026, titled a bill "Cannabis Decriminalization Act" but included retail licensing provisions characteristic of legalization. Ohio SB 124 used "legalization" in its title but capped possession at amounts typical of decriminalization statutes without authorizing sales.

The Cato paper recommends states adopt clear statutory definitions. Decriminalization bills should specify possession limits, civil fine structures, and expungement provisions without creating commercial licensing. Legalization bills should establish regulatory agencies, licensing tiers, tax rates, and testing standards. Hybrid models—decriminalized possession with medical-only sales—require explicit statutory language to avoid enforcement confusion.

For comprehensive background on state-level reform models and federal preemption questions, see the CannIntel topic hub on decriminalization versus legalization.

Federal Rescheduling Doesn't Mandate State Action

Schedule III reclassification under the Controlled Substances Act doesn't require states to legalize or decriminalize cannabis, preserving state sovereignty over intrastate commerce. The Cato analysis emphasizes that federal scheduling determines criminal penalties under 21 U.S.C. § 844 and research restrictions under 21 U.S.C. § 823, but doesn't preempt state prohibition.

States may maintain full prohibition even if DEA finalizes Schedule III. Conversely, states may maintain legalization frameworks regardless of federal schedule. This federalism dynamic has persisted since Colorado and Washington launched adult-use markets in 2014 while cannabis remained Schedule I.

The next procedural milestone: DEA's final rule on rescheduling, expected by October 2026 following the close of the public comment period on the August 2024 NPRM. State legislatures will continue drafting reform bills in the interim, and the Cato framework provides a reference standard for distinguishing policy models.